Nano LIFE, published by World Scientific Publishing Company, is a multidisciplinary journal that delves into the dynamic fields of bioengineering, biomedical engineering, and pharmaceutical science, providing a platform for researchers to disseminate their cutting-edge findings. With an ISSN of 1793-9844 and e-ISSN 1793-9852, this journal emphasizes the significance of nanoscale research in healthcare and technology, positioning itself as a vital resource for professionals and academics alike. Although currently categorized in the Q4 quartile for multiple scientific disciplines in 2023, its unique focus on the intersection of nanotechnology and life sciences aims to elevate the discourse in these rapidly evolving sectors. Researchers can anticipate publishing innovative methodologies and results, contributing to the overall understanding and application of nanotechnology in medicine. Located in Singapore, Nano LIFE not only serves the global research community but also reflects the growing interest in nanotechnology across diverse fields.

PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION is a distinguished journal dedicated to advancing the knowledge within the fields of Chemistry, Condensed Matter Physics, and Materials Science. Published by WILEY-V C H VERLAG GMBH in Germany, this journal has established a solid reputation since its inception in 1984, showcasing research aimed at understanding the intricate properties and behaviors of particulate systems. With an impressive Q2 ranking in its respective categories and Scopus ranks indicating a robust standing in the global research community, it serves as an essential resource for researchers, professionals, and students. Although it does not currently offer Open Access options, its comprehensive articles and reviews provide valuable insights that contribute significantly to the ongoing discourse in these scientific domains. As it prepares to celebrate four decades of publication, PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION continues to provide a vital platform for emerging knowledge, fostering innovation and collaboration among scientists dedicated to the study of particle systems.

MATERIALS TECHNOLOGY is a prestigious academic journal published by Taylor & Francis Ltd, based in the United Kingdom. With an ISSN of 1066-7857 and an E-ISSN of 1753-5557, this journal has established itself as a vital resource in the fields of Condensed Matter Physics, Materials Science, Mechanical Engineering, and Mechanics of Materials, earning a Q2 ranking in multiple categories as of 2023. With a rich publication history that dates back to the early 1970s, it serves as an essential platform for disseminating innovative research and developments in materials technology. Although not available through Open Access, the journal continues to attract contributions from leading researchers, ensuring high-quality articles that advance knowledge in the materials domain. The journal's commitment to excellence is reflected in its notable Scopus rankings, placing it within the 70th to 78th percentiles across several engineering and physics categories. As a vital resource for researchers, professionals, and students alike, MATERIALS TECHNOLOGY plays a critical role in shaping the future of materials science and engineering.

Nanomedicine, published by Future Medicine Ltd, is a premier academic journal dedicated to the rapidly evolving field of nanotechnology in medicine. With an emphasis on innovative research and applications, this journal encompasses a broad spectrum of topics including bioengineering, biomedical engineering, and nanoscience, among others. Featuring an impressive Q1 ranking in Development and multiple Q2 rankings across significant categories, it serves as a pivotal resource for researchers and professionals aiming to stay at the forefront of advancements in these disciplines. While the journal is not open access, it is accessible through various institutional subscriptions, ensuring wide dissemination of cutting-edge findings. Notably, it has achieved substantial impact within the scientific community, indicated by its high rankings in Scopus and overall commitment to enhancing the understanding and application of nanomedicine. This journal is a vital conduit for fostering collaborations and innovations that transcend traditional medical paradigms.

Nanomedicine Journal, published by Mashhad University of Medical Sciences, serves as a vital platform for research and developments in the dynamic field of nanotechnology applied to medicine. With an ISSN of 2322-3049 and an E-ISSN of 2322-5904, this Open Access journal, operational since 2013, makes cutting-edge research freely accessible to encourage collaborative efforts in this rapidly evolving domain. The journal navigates various areas, including bioengineering, biomedical engineering, materials science, and pharmacology, holding prestigious rankings in categories relevant to these fields. The 2023 Scopus Rankings reveal its significant standing within the scientific community, particularly with a 76th percentile in general medicine. By bridging the gap between laboratory technologies and clinical applications, the Nanomedicine Journal aims to empower researchers, professionals, and students alike to contribute to the innovative landscape of nanomedicine. With a convergence period extending from 2019 to 2024 and an established reputation, this journal is essential for those pursuing advancements in therapeutic solutions and diagnostics through nanotechnology.

Nanomaterials and Nanotechnology is a premier journal published by HINDAWI LTD, dedicated to advancing knowledge in the rapidly evolving fields of nanomaterials and nanoscale applications. Established as an Open Access platform since 2011, the journal aims to disseminate high-quality research that provides insights into nanotechnology's manifold aspects, including biotechnology, ceramics and composites, as well as electrical and electronic engineering. With a compelling impact factor reflected in its robust Scopus rankings—placing it in the 80th percentile in Engineering and the 72nd percentile in Biotechnology—it stands as a key resource for researchers, professionals, and students seeking to stay at the forefront of innovation in materials science. The journal occupies a distinguished position in the academic community, featuring studies that explore the synthesis, characterization, and application of nanomaterials, thereby contributing significantly to scientific discourse and technological advancement in this critical area.

DRUG DELIVERY is a premier academic journal published by TAYLOR & FRANCIS LTD, with a steadfast commitment to advancing research in the fields of medicine and pharmaceutical sciences. As an Open Access journal since 2017, it offers unparalleled accessibility to its high-quality content, making it an invaluable resource for researchers, professionals, and students alike. With an impressive 2023 impact factor, it ranks in the Q1 quartile for both Medicine (miscellaneous) and Pharmaceutical Science, evidencing its significant impact within the scientific community. The journal focuses on innovative drug delivery systems, therapeutics, and methodologies that enhance patient care and treatment options. Based in the United Kingdom, it has evolved since its inception in 1993 to create a richly diverse platform for scholarly dialogue and advancements in the pharmaceutical landscape. Researchers looking to stay at the forefront of drug delivery research will find DRUG DELIVERY an essential companion in their pursuits.

BioNanoScience is an esteemed academic journal published by SPRINGER, dedicated to the interdisciplinary field of bioengineering and biomedical engineering. With an ISSN of 2191-1630 and an E-ISSN of 2191-1649, the journal has established itself as a significant platform for sharing innovative research and developments in nanotechnology as applied to biomedical contexts. Although it operates under a subscription model, the journal maintains a strong impact within its field, achieving a Q3 quartile ranking in both categories for 2023 and has a solid standing in Scopus rankings, where it ranks #129 out of 303 in Biomedical Engineering and #87 out of 162 in Bioengineering. The journal not only aims to publish high-quality research, but also seeks to foster collaboration between scientists, engineers, and healthcare professionals to address pressing global health challenges through nanotechnology. As an essential resource for researchers, professionals, and students, BioNanoScience continues to contribute to the advancement of knowledge and innovation in bioengineering.

The Journal of Experimental Nanoscience, published by Taylor & Francis Ltd, is an esteemed open-access journal dedicated to advancing the field of nanoscience and its applications across various disciplines. Since its establishment, the journal has aimed to provide a comprehensive platform for researchers and professionals to disseminate innovative findings in nanotechnology, bioengineering, and materials science. With an ISSN of 1745-8080 and E-ISSN of 1745-8099, this journal has been pivotal in promoting high-quality research in its converged years from 2006 to 2024. Recognized for its contributions, it currently holds a Q3 ranking in core categories such as Bioengineering, Biomedical Engineering, Materials Science, and Nanoscience and Nanotechnology. Although its H-index is not specified, its Scopus ranks reflect its growing influence, with notable percentiles in various engineering fields. By offering open access since 2016, the Journal of Experimental Nanoscience enhances the accessibility of vital research to a global audience. Researchers, professionals, and students will find this journal an invaluable resource for staying abreast of the latest advancements and breakthroughs in nanoscience.

The International Journal of Biomaterials, published by HINDAWI LTD, is a premier platform for disseminating groundbreaking research in the fields of biomaterials and biomedical engineering. With an Open Access approach since 2009, this journal provides unhindered access to innovative studies and applications aimed at advancing medical technologies and improving patient outcomes. Notably ranked in the Q3 category for both Biomaterials and Biomedical Engineering in 2023, it serves as an essential resource for researchers, practitioners, and students alike. The journal's Scopus rankings, including a 49th percentile in Biomedical Engineering and a 40th percentile in Biomaterials, further underscore its growing prominence in the academic community. With contributions spanning from 2011 to 2024, the journal seeks to foster collaborative research and promote developments that enhance the understanding and application of biomaterials in healthcare.